Medical Device Industry Opposes Draft Bill Over Regulatory and Innovation Concerns
A draft Bill to update India's Drugs and Cosmetics Act faces opposition from pharmaceutical and medical device sectors, which argue it inadequately distinguishes medical devices from pharmaceuticals. Industry groups, including the Association of Indian Medical Device Industry, criticize the Bill for using drug-centric terms, criminalizing minor technical lapses, and lacking device-specific regulatory frameworks. They warn these provisions could hinder innovation, manufacturing, and India's goal to become a global medical device hub. The Bill is currently under inter-ministerial review with concerns raised to Health Minister J P Nadda.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 50%, Centre 50%, Right 0%). Overall sentiment is negative (35/100). Lens Score 47/100.
Outlets measured: indianexpress, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 1 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (32–38/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 10 Aug, 06:41 pm. Other outlets followed.